Antiviral medications are used to treat viral illnesses such the flu, hepatitis, and the human immunodeficiency virus (HIV). A variety of viruses can be treated with broad-spectrum antiviral medications.
Over the forecast period, the market expansion is anticipated to be driven by the rising acceptance of medications for the treatment of viral infections. For instance, the pharmaceutical company GlaxoSmithKline Plc announced in March 2019 that the National Medical Products Administration had approved Viread (tenofovir disoproxil fumarate), an oral antiviral drug for the treatment of chronic hepatitis B, for its updated safety data regarding the treatment of chronic hepatitis B in pregnant patients.
The class of medications known as antiviral pharmaceuticals is used to treat viral illnesses like hepatitis, HIV, and influenza, among others. These medications can be prescribed as tablets, liquids, injectable solutions, and powders for inhalation. Antiviral medications are used to get rid of viruses that cause illness from the body. Various antiviral drug classes, including protease inhibitors, reverse transcriptase inhibitors (NRTIs and NNRTIs), neuraminidase inhibitors, and DNA polymerase inhibitors, are offered on the market.
Antiviral Drugs Market- Segmental Analysis
By Drug class
- DNA polymerase inhibitors
- Reverse transcriptase inhibitors
- Protease inhibitors
- Neuraminidase inhibitors
- Others
The reverse transcriptase inhibitors segment is expected to register notable gains over the analysis timeline owing to rising diagnosis and treatment rate pertaining to HIV.
- By Indication
- Influenza
- HIV AIDS
- Hepatitis
- Herpes simplex virus (HSV)
- Coronavirus infection
- Others
The HIV AIDS segment presently dominates the market and is anticipated to showcase similar expansion trends in the ensuing years. This is credited to rising prevalence of HIV and absence of effective vaccines against the disease.
By Type
- Branded
- Generic
The generic segment is poised to capture a high revenue share over 2022-2030 owing to cost effectiveness and easy availability of generic drugs.
By Age group
- Adult
- Pediatric
- Geriatric
The geriatric segment is slated to grow substantially over the stipulated timeline as the elderly people are highly prone to various viral diseases and hence require anti-viral drugs to a massive extend.
Get Free Sample:- https://wemarketresearch.com/sample-request/antiviral-drugs-market/56/
Top Key Players:-
- AbbVie Inc
- Merck Co
- GlaxoSmithKline plc
- Aurobindo Pharma Limited
- Johnson Johnson
- Sun Pharmaceutical Industries Ltd
- Cipla, Inc
- Mylan N V
- Bristol-Myers Squibb
- Hoffmann-La Roche Ltd
- Abbott Laboratories
- AstraZeneca plc
- AbbVie Inc
- Schering-Plough Corporation
- Reddy’s Laboratories Ltd
- Novartis AG,
- Pfizer Inc
Interested in purchasing this Report? Click here:- https://wemarketresearch.com/purchase/antiviral-drugs-market/56/?license=single
Frequently Asked Questions (FAQ):
- How big is the antiviral drugs market?
- What is the antiviral drugs market growth?
- Which segment accounted for the largest antiviral drugs market share?
- Who are the key players in the antiviral drugs market?
- What are the factors driving the antiviral drugs market?
About We Market Research
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
We Market Research
Phone: +1(929)-450-2887
Email: [email protected]
